Registrar Doctor in Haematology | The Royal Marsden NHS Foundation Trust
| Dyddiad hysbysebu: | 22 Gorffennaf 2025 |
|---|---|
| Cyflog: | Heb ei nodi |
| Gwybodaeth ychwanegol am y cyflog: | £61,825 - £70,425 per annum |
| Oriau: | Llawn Amser |
| Dyddiad cau: | 21 Awst 2025 |
| Lleoliad: | Chlesea, SW3 6JJ |
| Cwmni: | The Royal Marsden NHS Foundation Trust |
| Math o swydd: | Cytundeb |
| Cyfeirnod swydd: | 7366961/282-C008-MED-B |
Crynodeb
A vacancy has arisen in the department for which we are seeking to appoint a clinical research fellow on a fixed term basis for 36 months. The post combines in-patient and out-patient work, caring for patients with a range of haematological malignancies, and will comprise a high proportion of research work including clinical trials and laboratory research. The candidate will be expected to submit a MDRes under the supervision of Dr Taussig. One focus will be on arginine deprivation in acute myeloid leukaemia.
The Royal Marsden is a world leader in cancer research, treatment and education. Together with our academic partner, The Institute of Cancer Research (ICR), we are the largest comprehensive cancer centre in Europe and the only National Institute of Health Research (NIHR) Biomedical Research Centre specialising in cancer in the UK.
Our mission is to continue to make a national and international contribution to cancer research and treatment, so that more people are cured and quality of life is improved for those with cancer. The Royal Marsden therefore plays an important role in championing change and improvement in cancer care through research and innovation, education and leading-edge treatment.
We have a reputation for delivering high quality performance. We were ranked joint first in the CQC national inpatient survey results, above average in national cancer patient experience survey and ranked first amongst teaching hospitals in the UK for our staff survey results.
Predominantly the Trust’s workload is from within the South West and West London Cancer Networks but, as a specialist cancer, the Trust has a high out-of-area referral rate for rare cancers, recurrent disease and treatment-related problems including international referrals. The Trust operates a shared care model with St George’s Healthcare NHS Trust for paediatric cancer.
The Royal Marsden is a world leader in cancer research, treatment and education. Together with our academic partner, The Institute of Cancer Research (ICR), we are the largest comprehensive cancer centre in Europe and the only National Institute of Health Research (NIHR) Biomedical Research Centre specialising in cancer in the UK.
Our mission is to continue to make a national and international contribution to cancer research and treatment, so that more people are cured and quality of life is improved for those with cancer. The Royal Marsden therefore plays an important role in championing change and improvement in cancer care through research and innovation, education and leading-edge treatment.
We have a reputation for delivering high quality performance. We were ranked joint first in the CQC national inpatient survey results, above average in national cancer patient experience survey and ranked first amongst teaching hospitals in the UK for our staff survey results.
Predominantly the Trust’s workload is from within the South West and West London Cancer Networks but, as a specialist cancer, the Trust has a high out-of-area referral rate for rare cancers, recurrent disease and treatment-related problems including international referrals. The Trust operates a shared care model with St George’s Healthcare NHS Trust for paediatric cancer.
Please see attached job description/person specification for a more detailed description of the role.
This advert closes on Tuesday 5 Aug 2025
Aelod balch o'r cynllun cyflogwyr Hyderus o ran Anabledd
Hyderus o ran Anabledd
Gwybodaeth am Hyderus o ran Anabledd
Yn gyffredinol, bydd cyflogwr Hyderus o ran Anabledd yn cynnig cyfweliad i unrhyw ymgeisydd sy'n datgan eu bod yn anabl ac yn bodloni'r meini prawf lleiaf ar gyfer y swydd fel y diffinnir gan y cyflogwr. Mae'n bwysig nodi, mewn rhai sefyllfaoedd recriwtio fel nifer fawr o ymgeiswyr, cyfnod tymhorol ac amseroedd prysur iawn, efallai y bydd y cyflogwr am gyfyngu ar y niferoedd cyffredinol o gyfweliadau a gynigir i bobl anabl a phobl nad ydynt yn anabl. Am fwy o fanylion ewch i Hyderus o ran Anabledd.